ET
Edward Tenthoff Piper Sandler Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
25
Avg Return
Past Year
Past Year
96%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
100%
Neutral
0%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Diagnostics & Research
Drug Manufacturers - General
Medical Instruments & Supplies
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Reiterated
| $37 |
56%
upside
| 1 | -1.2% |
0
%
| 14 Jan ‘26 3 days ago |
|
|
|
Overweight
Reiterated
| $110 |
72%
upside
| 3 | +20% |
0
%
| 13 Jan ‘26 4 days ago |
|
|
|
Overweight
Maintained
| $8 |
304%
upside
| 1 | +2.6% |
0
%
| 9 Jan ‘26 8 days ago |
|
|
|
Overweight
Reiterated
| $45 |
85%
upside
| 1 | -11% |
0
%
| 10 Dec ‘25 1 month ago |
|
|
|
Overweight
Reiterated
| $125 |
80%
upside
| 1 | -26% |
0
%
| 9 Dec ‘25 1 month ago |
|
|
|
Overweight
Reiterated
| $23 |
127%
upside
| 2 | +15% |
0
%
| 8 Dec ‘25 1 month ago |
|
|
|
Overweight
Reiterated
| $63 |
51%
upside
| 1 | +87% |
0
%
| 21 Nov ‘25 1 month ago |
|
|
|
Overweight
Reiterated
| $6 |
295%
upside
| 1 | +12% |
0
%
| 14 Nov ‘25 2 months ago |
|
|
|
Overweight
Reiterated
| $489 |
36%
upside
| 1 | -2.7% |
0
%
| 31 Oct ‘25 2 months ago |
|